NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
Back to search
Official data from USPTO
BIMZELX NAVIGATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIMZELX NAVIGATE
ST13
US500000097166158Class
44
Filing
97166158
Registration
7409217
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/04/2024
Trademark type
Word
Nice classes
44
Filing date
12/10/2021
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-09-00
First use in commerce
11/20/2023
Drawing code
4
Owner type
99
Owner location
Brussels, BE
Examiner
HERR, JENNA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
UCB Biopharma SRL
Representatives
Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing medical information on disease and disease management in the field of immunology; Medical information servicesproviding a patient adherence program to patients living with immunology diseases and their caregivers; Patient support and pharmaceutical adherence program in the nature of providing medical information on disease managementpatient wellness and assistance to patient in complying with instructions and directions for taking medicines for the treatment of immunology diseases; Providing a website featuring information for patients and healthcare professionals in the field of immunology
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/30/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/23/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/22/2024
EX2G
SOU EXTENSION 2 GRANTED
03/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/20/2024
IUAF
USE AMENDMENT FILED
02/28/2024
EXT2
SOU EXTENSION 2 FILED
02/28/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2023
EX1G
SOU EXTENSION 1 GRANTED
06/26/2023
EXT1
SOU EXTENSION 1 FILED
06/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/26/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2022
GNRT
NON-FINAL ACTION E-MAILED
09/20/2022
CNRT
NON-FINAL ACTION WRITTEN
09/20/2022
DOCK
ASSIGNED TO EXAMINER
09/19/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/21/2021
ALIE
ASSIGNED TO LIE
12/21/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2021
NWAP
NEW APPLICATION ENTERED
12/14/2021
Continuous trademark protection
Get notified about every new filing that threatens BIMZELX NAVIGATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.